← Leaderboards
Stephen E Sallan
Children'S Hospital Boston
$2,454,853
Attributed
$2,454,853
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2006–10$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$34,404,681 · 4
By mechanism
P01$34,289,681 · 3
M01$115,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Joyce E. Bischoff$21,924,378
- Stephen A Huang$1,857,877
- David P Olson$7,348,715
- Judah Folkman$11,710,747
- Stuart H Orkin$48,011,987
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAcute Lymphocytic LeukemiaChild (0-11)Cerebrospinal FluidNeoplasm /Cancer ChemotherapyClinical TrialsDoxorubicinAsparaginaseQuality Of LifeHuman TissuePediatric Neoplasm /CancerNeoplasm /Cancer GeneticsAdult Acute Lymphocytic LeukemiaBiomarkerBiologyBiologicalCommitBaseCardiotoxicityAdultCellsChildhoodAngiogenesisCancer Center
Grant awards (25)
Therapeutic Index of Acute Lymphoblastic Leukemia$3,395,115
P01 · FY2010 · CA · contact PI
Clinical Consortia (Pediatric & Adult)$513,343
P01 · FY2010 · CA · contact PI
Therapeutic Index of Acute Lymphoblastic Leukemia$3,333,857
P01 · FY2009 · CA · contact PI
Clinical Consortia (Pediatric & Adult)$504,380
P01 · FY2009 · CA · contact PI
Therapeutic Index of Acute Lymphoblastic Leukemia$3,239,854
P01 · FY2008 · CA · contact PI
Clinical Consortia (Pediatric & Adult)$489,222
P01 · FY2008 · CA · contact PI
Therapeutic Index of Acute Lymphoblastic Leukemia$3,211,219
P01 · FY2007 · CA · contact PI
Clinical Consortia (Pediatric & Adult)$485,069
P01 · FY2007 · CA · contact PI
Therapeutic Index of Acute Lymphoblastic Leukemia$3,217,162
P01 · FY2006 · CA · contact PI
Clinical Consortia (Pediatric & Adult)$347,839
P01 · FY2006 · CA · contact PI
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,307,331
P01 · FY2004 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,219,060
P01 · FY2003 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,067,890
P01 · FY2002 · CA
FIBROBLAST GROWTH FACTOR QUANTIFICATION IN CHILDREN$28,750
M01 · FY2002 · RR
CORE--ACUTE LYMPHOCYTIC LEUKEMIA CONSORTIA$0
P01 · FY2002 · CA
ENHANCING TREATMENT OUTCOMES IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2002 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$3,000,757
P01 · FY2001 · CA
FIBROBLAST GROWTH FACTOR QUANTIFICATION IN CHILDREN$28,750
M01 · FY2001 · RR
FIBROBLAST GROWTH FACTOR QUANTIFICATION IN CHILDREN$28,750
M01 · FY2001 · RR
CORE--ACUTE LYMPHOCYTIC LEUKEMIA CONSORTIA$0
P01 · FY2001 · CA
ENHANCING TREATMENT OUTCOMES IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2001 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA$2,957,583
P01 · FY2000 · CA
FIBROBLAST GROWTH FACTOR QUANTIFICATION IN CHILDREN$28,750
M01 · FY2000 · RR
CORE--ACUTE LYMPHOCYTIC LEUKEMIA CONSORTIA$0
P01 · FY2000 · CA
ENHANCING TREATMENT OUTCOMES IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2000 · CA